International Journal of Infectious Diseases 46 (2016) 56–60
HIV/AIDS - Research and Palliative Care 2016:8 183–193
AIDSFree Case study series
This publication is made possible by the generous support of the American people through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and the U.S. Agency for International Development (USAID) under the terms of Cooperative Agreement AID-OAA-A-14-00046....
The contents are the responsibility of AIDSFree and do not necessarily reflect the views of PEPFAR, USAID, or the U.S. Government.
more
Review
published: 12 August 2016 doi: 10.3389/fpubh.2016.00166
Frontiers in Public Health | www.frontiersin.org 1 August 2016 | Volume 4 | Article 166
Open Online Courses include topics in Global Health, are short and designed for self-study. They are available free and can be accessed by anyone. Most offer a certificate. The course topics are: Climate Change; Public Health; Refugee Health; Diseases in Developing Countries; Basic Epidemiology, etc....
more
Multilingual guide on the topic of protective vaccination for migrants in Germany.
The guide is available in 16 languages: Albanian, Arabic, Bulgarian, German, English, French,
Greek, Italian, Kurdish, Persian, Polish, Romanian,
Russian, Serbian, Croatian, Spanish, Turkish. For the versions i...n other languages go to http://www.ethno-medizinisches-zentrum.de/index.php?option=com_content&view=article&id=37&Itemid=40
more
Rueda S, et al. BMJ Open 2016;6:e011453. doi:10.1136/bmjopen-2016-011453
The primary role of Benin’s Department of Pharmacy and Medicines (DPMED) is to develop and apply the national pharmaceutical policy. The main objective of this policy is to ensure the availability and accessibility of quality medicines for the population. To fulfill its mandate, DPMED aims to stre...ngthen its regulatory capacity, including the issuance of licenses to pharmaceutical establishments and the registration of pharmaceutical products. Benin’s current registration system shares core concerns that are common to most developing countries, notably the capacity to evaluate and monitor the security, efficacy, and quality of medicines and other health products. It is currently characterized by 1) poor or inadequate traceability of records or regulations (example: a product’s marketing authorization [MA] is often hard to find); 2) lack of evidence used in the regulatory decision-making process (reasons behind special import authorization, i.e., products without valid MAs); 3) inconsistent and unsecured archiving system; 4) limited human resources; and 5) an inefficient information management system
more
Overview
Rev Panam Salud Publica 40(6), 2016
Standard Treatment Guideline
Procedures Manual - Medicines registration in Madagascar - 2016 version
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.